RICE HALL JAMES & ASSOCIATES, LLC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 226 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2021. The put-call ratio across all filers is 1.62 and the average weighting 0.7%.

Quarter-by-quarter ownership
RICE HALL JAMES & ASSOCIATES, LLC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$12,413,000
-67.6%
82,110
-68.8%
0.72%
-61.1%
Q2 2022$38,326,000
+16.7%
263,030
-5.0%
1.85%
+41.6%
Q1 2022$32,845,000
-15.5%
277,006
-1.8%
1.31%
-5.1%
Q4 2021$38,856,000
-1.4%
281,951
-0.6%
1.38%
-5.3%
Q3 2021$39,416,000
+39.6%
283,750
-2.4%
1.46%
+45.1%
Q2 2021$28,237,000
+56.2%
290,861
+9.9%
1.00%
+70.5%
Q1 2021$18,083,000264,5580.59%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q1 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 900,844$136,181,00079.57%
RP Management, LLC 1,111,111$167,967,00077.60%
JET CAPITAL INVESTORS L P 1,707,500$258,942,00053.95%
Alpine Global Management, LLC 373,999$56,537,00013.23%
Chicago Capital Management, LLC 154,585$23,443,00012.75%
FIFTH LANE CAPITAL, LP 140,000$21,164,00011.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 3,784,482$572,100,000,00010.85%
Eversept Partners, LP 637,139$96,316,3038.35%
EQUITEC PROPRIETARY MARKETS, LLC 187,100$28,284,0007.45%
HARVEST MANAGEMENT LLC 48,503$7,332,0005.92%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders